trump glp 1 coverage The Administration is delivering big news in Medicare! Through the Medicare GLP-1 Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50 monthly copay. It's a Trump admin shifts course on
Description
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.
| 50 comments on LinkedIn
Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity
Apitegromab (SRK-015), an investigational new drug developed by Scholar Rock, is a fully human IgG4 monoclonal antibody that specifically binds to human Pro-GDF8 or latent GDF8 without binding to mature GDF8 or other closely related growth factors
